Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Deputy Minister leads a space science outreach programme in Bloemfontein

2014-02-28

The Deputy Minister of Science and Technology, Michael Masutha and Mandla Maseko– the first black South African expected to go into space in 2015 – will participate in a Space Science Outreach Programme at the University of the Free State on Saturday 1 March 2014.

The event, taking place at the Bloemfontein Campus, is part of an outreach programme to raise awareness about South Africa’s advances in space science and technology and its benefits to society.

Mr Maseko will share his exciting experiences in the Axe Apollo Space Academy competition, a challenging event that included skydiving, aptitude tests and building and launching a rocket with about 600 learners from the surrounding areas. The 25-year-old from Mabopane near Pretoria will become the first black astronaut when he goes into space on the Lynx Mark II Shuttle, next year.

The outreach event will include activities such as telescope making and rocket launching. Workshops demonstrating the benefits of space science in areas such as earth observations, scientific research and development and human capital development, will also be conducted.

Among others, the open day will feature exhibitions such as the project to build the world’s largest telescope, the Square Kilometre Array and the recent launch into space of the country’s micro-satellite – ZACUBE1 built by post-graduate students at the Cape Peninsula University of Technology (CPUT).

Other exhibitors will include the Hartebeesthoek Radio Astronomy Observatory (HartRAO), the Agricultural Research Council, Denel Dynamics, the South African National Space Agency (SANSA) and the South African Weather Services (SAWS).

Officials from the provincial Department of Basic Education are also expected to attend.

Journalists are invited to the outreach

Venue: Economics Building, University of the Free State
Date: Saturday 1 March 2014
Time: 08:00

For more information, contact Veronica Mohapeloa at +27(0)82 882 3818 or +27(0)12 843 6788 or email veronica.mohapeloa@dst.gov.za OR David Mandaha at +27(0)72 126 8910 or david.mandaha@dst.gov.za

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept